A novel chromatin tether domain controls topoisomerase IIα dynamics and mitotic chromosome formation

• DOI: 10.1083/jcb.201303045
• Publication Date: 2013-11-11T21:59:25Z
• Authors: Andrew B. Lane; Juan F. Giménez-A...; Duncan J. Clarke
• Keywords: 0301 basic medicine; Nuclear Envelope; Mitosis; DNA; Chromatin; Chromosomes; Cell Line; Protein Structure, Tertiary; DNA-Binding Proteins; Histones; Muntjacs; 03 medical and health sciences; DNA Topoisomerases, Type II; Antigens, Neoplasm; Animals; Humans; Protein Isoforms; RNA Interference; RNA, Small Interfering; Protein Processing, Post-Translational; Research Articles; HeLa Cells; Protein Binding

DNA topoisomerase IIα (Topo IIα) is the target of an important class of anticancer drugs, but tumor cells can become resistant by reducing the association of the enzyme with chromosomes. Here we describe a critical mechanism of chromatin recruitment and exchange that relies on a novel chromatin tether (ChT) domain and mediates interaction with histone H3 and DNA. We show that the ChT domain controls the residence time of Topo IIα on chromatin in mitosis and is necessary for the formation of mitotic chromosomes. Our data suggest that the dynamics of Topo IIα on chromosomes are important for successful mitosis and implicate histone tail posttranslational modifications in regulating Topo IIα.